German Drug Manufacturer Agrees to $650 Million Settlement for Blood Thinner Medication

May 28, 2014 3:42 PM

8 0

The Boehringer Ingelheim group is headquartered in Ingelheim, Germany and is one of the world's 20 leading pharmaceutical companies. On Wednesday, the German drugmaker announced a settlement with the U.S. regarding its drug Pradaxa.

Pradaxa is a prescription blood thinner that lowers the chance of blood clots forming in your body and is typically prescribed to patients who have medical conditions such as atrial fibrillation, deep vein thrombosis, and/or pulmonary embolism. The German company has agreed to a $650 million settlem...

Read more

To category page